AdeTherapeutics is a Canada-based developer of products designed to reduce adhesion complications related to surgery.
“AdeTherapeutics’ product and approach are very promising and have significant potential in all minimally invasive and invasive ophthalmology procedures where fibrosis or scar tissue is a problem,” said Dr. Ahmed, in the release. “Unlike other surgeries, inability to control growth of fibrotic tissue in the eye is the difference between success and failure of a procedure. I am excited to be a part of AdeTherapeutics’ product development and clinical process to help solve a problem that has plagued ophthalmology for decades.”
Related Articles on Ophthalmology:
Patient Safety Tool: AAO’s Wrong-Site Surgery Checklist
Ophthalmologist Dr. Mary Davidian to Appear on NBC Medical News Program
Ophthalmologist on the Move: Dr. Dylan Yu Joins KS’s Genstler Eye Center
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.